Latest United States News

Brookside Energy has wrapped up its latest on-market share buy-back, cutting its share count by 7% post-consolidation and funding the program entirely from operating cash flow. The company will pause buy-back activity as it finalises a proposed U.S. ADS listing but signals future buy-backs remain part of its capital strategy.

Almonty Industries has been added to the Russell 1000 and 3000 indexes, marking a key milestone in its market capitalization growth and enhancing its visibility among institutional investors.

Verity Resources has kicked off a systematic soil sampling and geological mapping campaign across its 903km² PL123/2024 tenement in Botswana, targeting copper, nickel, cobalt, silver and gold mineralisation analogous to the nearby Selebi Ni-Cu mine.

Iondrive Limited has gained a significant boost from the Oklahoma Department of Commerce, receiving a Letter of Support and potential incentives valued at over US$15 million for scaling its rare earth recycling modules in the US.

Evion Group launches a systematic exploration campaign at its Carp Fluorspar Project in Nevada, targeting critical mineral supply amid US import reliance.

Pantera Minerals has delivered standout Phase 2 exploration results at its Gillham Project in Arkansas, revealing antimony grades up to 19.2% and silver assays as high as 63.8 g/t, setting the stage for imminent maiden drilling.

Elevra Lithium has commenced construction on its North American Lithium expansion, backed by a recent capital raise that fully funds the project. The expansion aims to boost spodumene concentrate output by up to 20% and reduce operating costs by mid-2027.

Centuria Capital Group has launched the retail component of its $100 million entitlement offer, aiming to raise approximately $35 million. The equity raising supports expansion in AI infrastructure and real estate funds management.

4DMedical has cleared a major regulatory hurdle with the Therapeutic Goods Administration approving its CT:VQ™ lung imaging software, paving the way for commercial use across Australia and strengthening its global footprint.

Imagion Biosystems has raised $3.75 million to fund the start of its Phase 1b/2 clinical trial for the MagSense HER2 imaging agent in the US, following FDA clearance. The capital raising involves a two-tranche share placement with free attaching options, led by CPS Capital.

OD6 Metals has dramatically expanded its Quinn Fluorspar Project in Nevada, staking 226 mining claims across seven project areas and uncovering multiple historic high-grade fluorspar occurrences. This strategic move positions the company to develop a district-scale operation supplying critical minerals to the US market.

Southern Cross Electrical Engineering (ASX:SXE) has launched a non-underwritten Share Purchase Plan targeting up to $15 million at $4.00 per share, matching its recent institutional placement price. The raise aims to support working capital for new projects and provide flexibility for future acquisitions.